Carlene MacMillan, M.D., a Harvard-trained double board-certified adult and child psychiatrist, is the Chief Medical Officer at Osmind. Osmind is a technology platform that enables clinicians to deliver breakthrough mental health treatments including ketamine and transcranial magnetic stimulation. She is on the Board of Directors of the Clinical TMS Society and the Co-Chair of the Insurance Committee. She is the co-Chair of the American Academy of Child and Adolescent Psychiatry Consumer Issues Committee. Dr.MacMillan participates in multiple national and local committees and workgroups on behalf of the American Psychiatric Association to advance the practice and reimbursement of measurement-based care and new psychiatric technologies. She practices clinically as the co-founder of Fermata, an interventional psychiatric group practice and clinical trial site for rapid acting mental health treatments in New York City.